Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study

Economic impact of immunoglobulin replacement therapy in secondary immunodeficiency to hematological cancer: a single center observational study

This is the first report of the health economic benefits derived from preventing infections through Immunoglobulin Replacement Therapy (IgRT) in patients with secondary immunodeficiency due to hematological malignancies. We conducted a retrospective population-based cohort study using patient medica...

Full description

Bibliographic Details
Main Authors: Luciana del Campo Guerola, Ana Andrea García Sacristán, Antonio Portolés, Maricruz Jasso, Teresa Guerra-Galán, Eduardo de la Fuente-Munoz, María Palacios-Ortega, Miguel Fernández-Arquero, Cristina Cuesta-Mínguez, Aránzazu Rodríguez-Sanz, Ascensión Peña-Cortijo, Marta Polo, Marta Mateo Morales, Eduardo Anguita-Mandly, Teresa Benítez Jiménez, Celina Benavente Cuesta, Silvia Sánchez-Ramón
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Series:Frontiers in Immunology
Subjects:
secondary immunodeficiency
immunoglobulin replacement therapy
economic impact
infections
ICU - intensive care unit
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1413231/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1413231/full

Similar Items